Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Curran

Showing results (961-970 of 965) with videos related to

Pageof 97
Sort By:
You have reached the last page of results.This site can display upto 965 results.
Blood Advances|March 24, 2025
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapyHannah Lust, Liora M Schultz, Soyang Kwon, et al.
Blood Advances|October 6, 2025
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemiaYannis K Valtis, Chenyu Lin, David Nemirovsky, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug DesignKatherine L Lee, Catherine M Ambler, David R Anderson, et al.
Blood|December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
Science (New York, N.Y.)|September 22, 2022
Termite sensitivity to temperature affects global wood decay ratesAmy E Zanne, Habacuc Flores-Moreno, Jeff R Powell, et al.
Pageof 97

Showing results (961-970 of 965) with videos related to

Sort By:
Pageof 97
You have reached the last page of results.This site can display upto 965 results.
Blood Advances|March 24, 2025
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapyHannah Lust, Liora M Schultz, Soyang Kwon, et al.
Blood Advances|October 6, 2025
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemiaYannis K Valtis, Chenyu Lin, David Nemirovsky, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug DesignKatherine L Lee, Catherine M Ambler, David R Anderson, et al.
Blood|December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
Science (New York, N.Y.)|September 22, 2022
Termite sensitivity to temperature affects global wood decay ratesAmy E Zanne, Habacuc Flores-Moreno, Jeff R Powell, et al.
Pageof 97